Antioxidant activity of melatonin in Chinese hamster ovarian cells: Changes in cellular proliferation and differentiation

Biochemical and Biophysical Research Communications

Volumn 302, Issue 3, 2003, Pages 625-634

  Sainz, Rosa M ^a   Mayo, Juan C ^a   Tan, Dun Xian ^a   Lopez Burillo, Silvia ^a   Natarajan, Mohan ^a   Reiter, Russel J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cancer; CHO cells; Differentiation; Glutathione; Melatonin; Proliferation; Redox state

Indexed keywords

ALPHA TOCOPHEROL; GLUTATHIONE; MELATONIN; PLANT EXTRACT; RESVERATROL; TROLOX C;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CELL STRUCTURE; CELL TRANSFORMATION; CHINESE HAMSTER; CHO CELL; CONCENTRATION RESPONSE; CULTURE MEDIUM; FEMALE; FIBROBLAST; FLOW CYTOMETRY; MITOSIS INHIBITION; NONHUMAN; OXIDATION REDUCTION STATE; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; SPINDLE CELL;

CRICETINAE; CRICETULUS GRISEUS;

EID: 0037436851     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00230-4     Document Type: Article

References (43)

1. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12:1991;151-180.
2. Hardeland R., Balzer I., Poeggeler B., Fuhrberg B., Uria H., Behrmann G., Wolf R., Meyer T.J., Reiter R.J. On the primary functions of melatonin in evolution: mediation of photoperiodic signals in a unicell, photooxidation, and scavenging of free radicals. J. Pineal Res. 18:1995;104-111.
3. Reiter R.J. Melatonin: the chemical expression of darkness. Mol. Cell. Endocrinol. 79:1991;C153-C158.
4. Reppert S.M. Melatonin receptors: molecular biology of a new family of G protein-coupled receptors. J. Biol. Rhythms. 12:1997;528-531.
5. Acuna-Castroviejo D., Martin M., Macias M., Escames G., Leon J., Khaldy H., Reiter R.J. Melatonin, mitochondria, and cellular bioenergetics. J. Pineal Res. 30:2001;65-74.
6. Benitez-King G. PKC activation by melatonin modulates vimentin intermediate filament organization in N1E-115 cells. J. Pineal Res. 29:2000;8-14.
7. Carlberg C. Gene regulation by melatonin. Ann. N. Y. Acad. Sci. 917:2000;387-396.
8. Tan D.X., Chen L.D., Poeggeler B., Manchester L.C., Reiter R.J. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1:1993;57-63.
9. Reiter R.J., Tan D.X., Sainz R.M., Mayo J.C., Lopez-Burillo S. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J. Pharm. Pharmacol. 54:2002;1299-1321.
10. Blask D.E., Sauer L.A., Dauchy R.T. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr. Top. Med. Chem. 2:2002;113-132.
11. Blask D.E., Sauer L.A., Dauchy R.T., Holowachuk E.W., Ruhoff M.S., Kopff H.S. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Res. 59:1999;4693-4701.
12. Xi S.C., Tam P.C., Brown G.M., Pang S.F., Shiu S.Y. Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells. J. Pineal Res. 29:2000;172-183.
13. Cerutti P.A. Prooxidant states and tumor promotion. Science. 227:1985;375-381.
14. Karbownik M., Lewinski A., Reiter R.J. Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants. Int. J. Biochem. Cell Biol. 33:2001;735-753.
15. Fang Y., Yang S., Wu G. Free radicals, antioxidants, and nutrition. Nutrition. 18:2002;872.
16. Reiter R.J., Tan D.X., Burkhardt S., Manchester L.C. Melatonin in plants. Nutr. Rev. 59:2001;286-290.
17. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106:1980;207-212.
18. Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 27:1999;612-616.
19. Blask D.E., Wilson S.T., Zalatan F. Physiological melatonin inhibition of human breast cancer cell growth in vitro: evidence for a glutathione-mediated pathway. Cancer Res. 57:1997;1909-1914.
20. Browning C., Beresford I., Fraser N., Giles H. Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors. Br. J. Pharmacol. 129:2000;877-886.
21. Blask D.E., Hill S.M. Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. J. Neural. Transm. Suppl. 21:1986;433-449.
22. Witt-Enderby P.A., Dubocovich M.L. Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells. Mol. Pharmacol. 50:1996;166-174.
23. Browning C., Beresford I., Fraser N., Giles H. Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors. Br. J. Pharmacol. 129:2000;877-886.
24. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220.
25. Kampa M., Hatzoglou A., Notas G., Damianaki A., Bakogeorgou E., Gemetzi C., Kouroumalis E., Martin P.M., Castanas E. Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr. Cancer. 37:2000;223-233.
26. Holian O., Walter R.J. Resveratrol inhibits the proliferation of normal human keratinocytes in vitro. J. Cell. Biochem. Suppl. 36:2001;55-62.
27. Wolter F., Akoglu B., Clausnitzer A., Stein J. Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J. Nutr. 131:2001;2197-2203.
28. Bhat K.P., Pezzuto J.M. Cancer chemopreventive activity of resveratrol. Ann. N. Y. Acad. Sci. 957:2002;210-229.
29. Surh Y.J., Hurh Y.J., Kang J.Y., Lee E., Kong G., Lee S.J. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett. 140:1999;1-10.
30. del Bello B., Paolicchi A., Comporti M., Pompella A., Maellaro E. Hydrogen peroxide produced during γ-glutamyl transpeptidase activity is involved in prevention of apoptosis and maintenance of proliferation in U937 cells. FASEB J. 13:1999;69-79.
31. Chinery R., Beauchamp R.D., Shyr Y., Kirkland S.C., Coffey R.J., Morrow J.D. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. Cancer Res. 58:1998;2323-2327.
32. Suzuki Y.J., Forman H.J., Sevanian A. Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 22:1997;269-285.
33. Frank G.D., Eguchi S., Yamakawa T., Tanaka S., Inagami T., Motley E.D. Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II. Endocrinology. 141:2000;3120-3126.
34. Burdon R.H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 18:1995;775-794.
35. Burdon R.H., Gill V. Cellularly generated active oxygen species and HeLa cell proliferation. Free Radic. Res. Commun. 19:1993;203-213.
36. Zhang Y., Zhao W., Zhang H.J., Domann F.E., Oberley L.W. Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res. 62:2002;1205-1212.
37. Cos S., Blask D.E., Lemus-Wilson A., Hill A.B. Effects of melatonin on the cell cycle kinetics and estrogen-rescue of MCF-7 human breast cancer cells in culture. J. Pineal Res. 10:1991;36-42.
38. Cini G., Coronnello M., Mini E., Neri B. Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat. Cancer Lett. 125:1998;51-59.
39. Cos S., Fernandez R., Guezmes A., Sanchez-Barcelo E.J. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res. 58:1998;4383-4390.
40. Cos S., Fernandez R. Melatonin effects on intercellular junctional communication in MCF-7 human breast cancer cells. J. Pineal Res. 29:2000;166-171.
41. Bordt S.L., McKeon R.M., Li P.K., Witt-Enderby P.A., Melan M.A. N1E-115 mouse neuroblastoma cells express MT1 melatonin receptors and produce neurites in response to melatonin. Biochim. Biophys. Acta. 1499:2001;257-264.
42. Witt-Enderby P.A., MacKenzie R.S., McKeon R.M., Carroll E.A., Bordt S.L., Melan M.A. Melatonin induction of filamentous structures in non-neuronal cells that is dependent on expression of the human mt1 melatonin receptor. Cell Motil. Cytoskeleton. 46:2000;28-42.
43. Puck T.T., Webb P., Johnson R. Cyclic AMP and the reverse transformation reaction. Ann. N. Y. Acad. Sci. 968:2002;122-138.